Spiriva first available therapy in new inhaler technology

Inhaler technology that revolutionises how medication is delivered to the lungs is now available in Australia and set to become the delivery platform for a range of inhaled therapies, says Boehringer Ingelheim. Boehringer Ingelheim confirmed that Spiriva (tiotropium bromide 5mg) is the first therapy available in the new Respimat Soft Mist Inhaler and will be